Abstract:As genotypic and phenotypic mutations that enhance survivability are preserved during tumor evolution, some cancer cells tend to develop resistance to a particular programmed death, leading to the failure of cancer monotherapy. Fortunately, the combinational therapy of apoptosis and ferroptosis holds potential for addressing this tumor heterogeneity. Herein, a multifunctional free radical initiator was prepared by coating DHA-loaded mesoporous polydopamine (MPDA) nanospheres with Fe3+-tannic acid (TA) complexes and hyaluronic acid (HA) to achieve oxidative stress amplification and apoptosis/ferroptosis sensitization. This nanoplatform MPDA/DHA@Fe-TA@HA, denoted as MDTFH, was equipped with active targeting and tumor microenvironment (TME) activation, facilitating precise delivery and tumor-specific toxicity of chemotherapeutic agents, DHA. Upon exposure to the HAase-rich and acidic TME, the HA coating and Fe-TA networks would dissociate gradually, triggering the controlled release of Fe3+ and internal DHA. Subsequently, the Fe3+/Fe2+ conversion driven by glutathione (GSH) depletion would catalyze the Fenton reaction and DHA toxification to produce OH and C, that is, chemodynamic therapy (CDT) and chemotherapy (CT) were activated, respectively. Moreover, the superior photothermal therapy (PTT) effect stimulated by NIR irradiation could improve the efficacy of CDT and CT, which together with hyperthermia-induced tumor sensitivity intensify oxidative stress and lipid peroxidation, thus leading to apoptosis and ferroptosis. It was demonstrated in a 4T1 tumor-bearing mice model that MDTFH can significantly inhibit tumor growth through synergistic PTT/CT/CDT effects. Overall, this work provides a feasible paradigm to design multimodal therapeutic strategies inducing ferroptosis and apoptosis for cancer precision therapy. Schematic illustration of the construction process of MDTFH and its antitumor effects via PTT/CT/CDT synergy for apoptosis/ferroptosis induction.

A multimodal therapeutic nano-prodrug as oxidative stress amplifier induces apoptosis and ferroptosis for cancer therapy

A Multimodal Therapeutic Nano-Prodrug As an Oxidative Stress Amplifier Induces Apoptosis and Ferroptosis for Cancer Therapy

Targeted Gsh-Exhausting And Hydroxyl Radical Self-Producing Manganese-Silica Nanomissiles For Mri Guided Ferroptotic Cancer Therapy

Cancer-Erythrocyte Membrane-Mimicking Fe3O4 Nanoparticles and DHJS for Ferroptosis/Immunotherapy Synergism in Tumors.

Mechano‐Responsive Leapfrog Micelles Enable Interactive Apoptotic and Ferroptotic Cancer Therapy

Oxidative Stress-Amplified Nanomedicine for Intensified Ferroptosis-Apoptosis Combined Tumor Therapy.

Photothermal Nanozymatic Nanoparticles Induce Ferroptosis and Apoptosis Through Tumor Microenvironment Manipulation for Cancer Therapy

A pH-sensitive imidazole grafted polymeric micelles nanoplatform based on ROS amplification for ferroptosis-enhanced chemodynamic therapy

Enhanced ferroptosis therapy with a "nano-destructor" by disrupting intracellular redox and iron homeostasis

Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy

A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin

Targeting ferroptosis synergistically sensitizes apoptotic sonodynamic anti-tumor nanotherapy

A Glutathione-Responsive Polyphenol - Constructed Nanodevice for Double Roles in Apoptosis and Ferroptosis

Dual-responsive and NIR-driven Free Radical Nanoamplifier with Glutathione Depletion for Enhanced Tumor-Specific Photothermal/thermodynamic/chemodynamic Synergistic Therapy.

Amplification of oxidative stress with a hyperthermia-enhanced chemodynamic process and MTH1 inhibition for sequential tumor nanocatalytic therapy

Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis

Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy

Tumor-targeted supramolecular catalytic nanoreactor for synergistic chemo/chemodynamic therapy via oxidative stress amplification and cascaded Fenton reaction

A ferroptosis-reinforced nanocatalyst enhances chemodynamic therapy through dual H2O2 production and oxidative stress amplification

Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.

A Multifunctional Nanocatalytic Metal-Organic Framework As a Ferroptosis Amplifier for Mild Hyperthermia Photothermal Therapy